C-reactive protein and procalcitonin levels in prostate cancer.

Ilktac A., Kalkan S., Çalışkan S.

International journal of clinical practice, vol.75, no.4, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 75 Issue: 4
  • Publication Date: 2021
  • Doi Number: 10.1111/ijcp.13935
  • Journal Name: International journal of clinical practice
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
  • Bezmialem Vakıf University Affiliated: Yes


Aim Prostate cancer (PCa) is one of the most common cancers among men in the world. Prostate-specific antigen is the most used biomarker for PCa diagnosis. In this study, we aimed to measure the procalcitonin (PCT) and C-reactive protein (CRP) levels in patients with PCa.